2015 CAPA Candidates Profiles For President-elect (alphabetic order): Dr. Ping Tang Dr. Ping Tang is a Professor at Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY. She earned her MD from Sichuan University School of Medicine and PhD from University of Texas MD Anderson Cancer Center. Her post-graduate training includes a research fellowship at Harvard Medical School in Boston, post-doctoral training at MD Anderson Cancer Center in Houston, AP/CP residency training at North Shore University Hospital in Long Island and Surgical Pathology fellowship at Yale-New Haven Hospital in New Haven. Dr. Tang is the Director of Breast Pathology and Breast Pathology Fellowship Program and Co- Director of Surgical Pathology Residency Rotation. Her funded research focuses on the use of immunohistochemical analysis to identify the subgroup of breast cancer with high risk for bone metastasis and the subgroup of ductal carcinoma in situ with high risk to progress to invasive carcinoma. She has published over 60 peer-reviewed research articles and 4 book chapters. Dr. Tang has been invited speakers at numerous national and international meetings. She have also been served as faculty member on several CAP courses on ER, PR, HER2 testing in breast cancer, including a recent online course for ER/PR testing. Dr. Tang has been an active member of CAPA since 2004. She was Co-Chair of Education Committee and Executive committee member (2009-2011). Dr. Huamin Wang Dr. Wang received his M.D. from Tongji Medical College, Huazhong University of Science & Technology in 1987 and his Ph.D. in Biochemistry & Molecular Biology from the University of Texas (UT) Graduate School of Biomedical Sciences (Houston, TX) in 1999. He did his residency at the UT Medical School (Houston) from 1999 to 2003 and his fellowship in Selective Surgical Pathology at UT MD Anderson Cancer Center (MDACC) from 2003 to 2004. Dr. Wang is currently a tenure associate professor of pathology. Dr. Wang has authored more than 160 peer-reviewed publications. He received many awards for his research, including the Career Development Award from the American Association for Cancer Research. He has served as PI, co-pi, or co-investigator for more than 20 research. As one of the experts in GI pathology, he was selected to serve on the American Joint Committee on Cancer (AJCC) Foregut Task Force for the 7th edition of the AJCC Cancer Staging Manual. Dr. Wang has been a loyal member of CAPA since 2003. He has served on the CAPA Nomination, Bylaws and Award Committee from 2009 to 2010 and is currently the Secretary and EC Members for CAPA. He has helped to solicit and to organize 11 CAPA speakers for
2014 Chinese National Pathologists Annual Meeting in Chongqing, China. He is eager for an opportunity to lead CAPA into a brighter future. For CAPA Treasurer: Dr. Zongming (Eric) Chen Dr. Chen is currently an associate pathologist and the director of Immunohistochemistry for Geisinger Medical Laboratories at Geisinger Medical Center, Danville. He also holds an affiliated academic appointment in Temple University School of Medicine as a clinical assistant professor. Before that he was an assistant professor of pathology in Northwestern University Feinberg School of Medicine at Chicago from 2008-2012. He received his MD from Zhejiang University School of Medicine, China. He also received a PhD in microbiology and immunology from the University of Minnesota. Dr. Chen received his pathology residency training in anatomic and clinical pathology at Washington University at St. Louis and completed fellowships in surgical pathology at Washington University at St. Louis and a fellowship in GI and liver pathology at Johns Hopkins Medical Institutions at Baltimore. Dr. Chen has been an active CAPA member since 2004 (including Hua Tuo Society of Pathology from 2004-2005). He was the first winner of the CAPA Award for Best Abstract by Trainee in 2006. For EC members (alphabetic order): Dr.Guoping Cai Dr. Guoping Cai obtained his medical degree and a master degree from Wenzhou Medical College, China. He completed his residency training in Anatomic and Clinical Pathology at New York University in 2005. After a one-year fellowship training in Cytopathology at New York University, he began his pathology practice as an Assistant Professor in University of Pittsburgh Medical Center. In 2009, he joined the faculty of Yale University. Dr. Cai is currently an Associate Professor of Pathology at Yale School of Medicine and an Attending Pathologist at Yale-New Haven Hospital. Dr. Cai has authored over 60 papers and five book chapters, and given over 50 presentations at national and international pathology meetings. He has received several awards from the USCAP and Papanicoloau Society of Cytopathology (PSC). He sits on the editorial board of Cancer Cytopathology, and is a reviewer for a number of other journals. He is currently a member of the Education and Training Task Force of PSC. Dr. Cai is an active member of Chinese American Pathologists Association (CAPA) and has served the Membership Committee of CAPA. He is also a strong advocate for promoting exchange and collaboration in pathology education, training and practice with colleagues in China. As an executive board member of CAPA, Dr. Cai will continue to advocate the missions
of CAPA to advance practice of pathology among our members and to promote communication of American and Chinese Pathology Societies. Dr. Chen Liu Dr. Chen Liu is a professor and the associate chair of the Department of Pathology, Immunology, and Laboratory Medicine at the University of Florida. He is also the director of the GI/Liver Pathology Division and the endowed chair of liver research. Dr. Liu received his M.D. degree in China and his Ph.D. from the University of Pennsylvania. Dr. Liu underwent his residency training at the Medical College of Pennsylvania and his fellowship training at the University of Texas' MD Anderson Cancer Center and research fellowship training at the Scripps Research Institute. Dr. Liu is a well-established GI/liver pathologist and an NIH-funded liver disease investigator. He is a recognized expert in viral hepatitis, liver cancer and graft-versus-the host disease. Dr. Liu has published more than 200 peer-reviewed articles and book chapters, including chapters in Robbin and Cotran's Pathological Basis of Disease. Additionally, he has given many lectures at various state, regional, national and international conferences and universities. He is an associate editor for Laboratory Investigation and the Precision Medicine section editor for the Archives of Pathology & Laboratory Medicine. Dr. Lizhen Gui Dr. Gui is currently an associate pathologist at Northwest Arkansas Pathology Associates, Fayetteville, Arkansas. Before that she was an assistant professor of pathology in University of Mississippi Medical Center at Jackson, Mississippi, from 2002 to 2005. Dr. Gui received her MD from Zhongshan Medical University, Guangzhou, China. She also received a PhD in molecular biology from the University of Minnesota. Dr. Gui received her pathology residency training in anatomic and clinical pathology at University of Mississippi Medical Center, Jackson, Mississippi, and completed a fellowship in surgical pathology at University of Southern California, Los Angeles. Dr. Gui has been an active CAPA member since 2005. Dr. Huan-You Wang Huan-You Wang, M.D., Ph.D. is currently Professor of Pathology, Director of Hematopathology Fellowship Program, and Co-Director of Hematopathology at the Department of Pathology, UC San Diego. After his medical training at Tongji Medical University in Wuhan, Dr. Wang was recruited to the Peking University as an Instructor of Pathology. As a Visiting Scholar to UC San Diego in 1992, He then obtained his Ph.D. from the Molecular Pathology program of UC San Diego in 2000,
and subsequently had his Anatomic and Clinical Pathology Training at the University of Virginia from 2000-2004. After finishing his Hematopathology fellowship at the University of Pennsylvania in 2005, he served as an Assistant Professor of Pathology in the Department of Pathology from 2005-2009 at the University of Texas Southwestern Medical Center in Dallas. During this period, he served as Director of Hematology and Bone Marrow Lab at Parkland Memorial Hospital and Clinics from 2007-2009, and Director of Molecular Genetics Pathology fellowship (2008-2009). Dr. Wang has published 60 research articles, 5 book chapters including one for the 8th Edition of Williams Hematology. He is the member of editorial boards of 3 journals including the International Journal of Clinical and Experimental Pathology and served as editorial member of 2 other journals. He is an invited reviewer of multiple journals including Blood and Cancer. He is the Founding Member of the San Diego Society of Hematopathology and he was actively involved in the CAPA as a local host during the CAPA meeting in March 2014 in San Diego. Dr. Hua Yang Dr. Yang graduated from Shanghai Medical University in 1983 and did his graduate study in the Department of Surgery in Zhong Shan Hospital. He also did clinical fellowship training in Japan National Cardiovascular Centre in Osaka, Japan. He later moved to Canada. He finished his Residency in Anatomic Pathology at Dalhousie University in Halifax, Canada. He also did Clinical Fellowship training in Breast Pathology at Mount Saint Hospital in University of Toronto. Dr. Yang currently is the Breast Pathology Specialty Group Leader at the Department of Pathology in University of Calgary. He is also an executive member of The Provincial Breast Cancer Care Committee in the province of Alberta, Canada. Dr. Yang is specialized in cancer diagnosis, particularly in breast cancer as well as cancer prognostic/predictive markers. He has published 5 book chapters, 35 journal articles and numerous international meeting presentations. Dr. Lanjing Zhang Lanjing Zhang, MD, MS, is the gastrointestinal and liver pathology director at University Medical Center of Princeton at Plainsboro, an associate member of Rutgers Cancer Institute of New Jersey and a clinical assistant professor of pathology and laboratory medicine at Rutgers Robert Wood Johnson Medical School. He is also an adjunct professor at Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China, and a guest professor at PLA general (301) Hospital, Beijing, China. Dr. Zhang pursued a postdoctoral research fellowship at University of Michigan Medical School, Ann Arbor, MI after earning his medical and master degrees from Tongji Medical University, Wuhan, China in 2000. Upon finishing his postdoctoral research fellowship in 2006, he
completed his pathology residency training at Mount Sinai Medical Center, New York in 2010 and gastrointestinal and liver pathology fellowship at Hospital of the University of Pennsylvania, Philadelphia, PA in 2011. Dr. Zhang was an Executive Committee member of CAPA 2011-2013. He has also founded or chaired several successful meetings or committees, notably Princeton integrated pathology symposia, and the Resident and fellow s annual symposia and Pathology section meetings of Association of Chinese American Physicians. His contribution and leadership have also been recognized by many awards, including Zu-Hua Gao Outstanding Service Award of Chinese American Pathologist Association, Distinguished Leadership Award of Association of Chinese American Physicians and Distinguished Service Award of American Chinese Medical Exchange Society and others. Dr. Jun Zhang Jun Zhang, MD, has been a consultant in Division of Anatomic Pathology at Mayo Clinic Rochester MN for 10 years, published more than 50 peer-reviewed articles, and was promoted to an associate professor at Mayo Clinic College of Medicine in 2012, and currently is co-director of molecular pathology lab. Finished pathology residency training at Temple University in 2013; Finished cytopathology and molecular pathology fellowships at the Johns Hopkins Hospital in 2005 before joining Mayo Clinic in the same year. A life-long CAPA member since 2005; An Executive Committee member of CAPA from 2011 to 2013; And served as co-chair of CAPA Web/Publication Committee from 2011 to 2012. Dr. Zhongren (David) Zhou Dr. Zhongren (David) Zhou is a surgical pathologist with subspecialized as gastrointestinal pathology and cytopathology. He was trained in North Shore University Hospital and Boston University. He had his Cytopathology Fellow in Baylor Medical College and his surgical pathology fellow in MD Anderson Cancer Center. Now he is an associate professor in University of Rochester and interim Director of Cytopathology in University of Rochester Medical Center. He is involved in many clinical and translation research. His research focuses on the biomarkers of esophageal adenocarcinoma and early precancerous lesions. He tries to develop new pathological tests for early diagnosis and prevention of esophageal cancer. He joins multiple national and international societies including USCAP, CAP and American Society of Cytopathology (ASC). He is actively involved in CAPA activity. He is also a committee member of Research and Current Concepts Committee in ASC and TCGA GI committee in National Cancer Institute.